At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 350 enrolled
Drug / intervention
Misoprostol +1 moredrug
Likely dose
Misoprostol 75 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled Trial of Oral Misoprostol for Labor Augmentation
University of Texas Southwestern Medical Center·interventional·Posted May 21, 2009·Updated Nov 15, 2012
In Brief
A Phase 4 clinical trial evaluating Misoprostol and Oxytocin for Labor Augmentation. Completed, enrolled 350 participants across 1 site.
Detailed Summary
This is a prospective, randomized, controlled trial designed to examine the efficacy of oral misoprostol for labor augmentation compared to a standard regimen of intravenous oxytocin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLabor Augmentation
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2008
First PostedMay 2009
Primary CompletionJan 2011
TodayJul 2026
First PostedMay 21, 2009
Enrollment StartDec 1, 2008
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 17.1 years ago
Interventions
Misoprostoldrug
75 micrograms orally every 4 hours for up to 2 doses.
Oxytocindrug
Intravenous oxytocin will be administered per the established Labor and Delivery protocol at Parkland Memorial Hospital